IL17A and obesity disorder: In this sense, an IL-1R1 receptor deficiency appears to promote an environment with increased IL-17 gene expression, either for a more pro-inflammatory environment contributing to increased intestinal permeability or for a compensatory action attempting to restore epithelial integrity, as well as to contain gut dysbiosis in the context of obesity [32].